Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$20.9M
8 rounds on record
Latest round
$7M
Venture round · Nov 2023 · 2 yr ago
Team
11
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Backers
1
UTEC
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 30, 2025 Took on debt financing $4M · SEC Form D Mar 31, 2025 Took on debt financing $3.6M · SEC Form D Jan 30, 2025 Took on debt financing $600k · SEC Form D Nov 9, 2023 Raised a round Venture round $7M · SEC Form D Sep 14, 2022 Took on debt financing $5M · SEC Form D Feb 2, 2021 Raised a round Venture round $4.2M · SEC Form D Nov 19, 2019 Raised a round Venture round $5.7M · SEC Form D Jun 13, 2018 Raised a round Venture round $4M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Oct 2025 $4M — SEC Form D
Debt Financing Mar 2025 $3.6M — SEC Form D
Debt Financing Jan 2025 $600k — SEC Form D
Venture round Nov 2023 $7M — SEC Form D
Debt Financing Sep 2022 $5M — SEC Form D
Venture round Feb 2021 $4.2M — SEC Form D
Venture round Nov 2019 $5.7M — SEC Form D
Venture round Jun 2018 $4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity ELIXIRGEN THERAPEUTICS, INC. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Akihiro KoExecutive Officer, DirectorSEC Form D
Minoru KoDirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

We develop life-changing therapies, focusing on rare diseases and aging-associated diseases using our cutting-edge technologies.

People

Akihiro Ko
Executive Officer, Director
Minoru Ko
Director
Maiko Katadae
Director
Naonori Kurokawa
Director
Hiroaki Kobayashi
Director
Thomas White
Director
Shauna Callahan
Director
Jeffrey Cleland
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Baltimore United States
HQ

Financials

Total raised
$34.1M
Latest round
Debt Financing
Funding rounds
8
Funding rounds
Round Announced Amount
Debt Financing 2025 $4M Details
Debt Financing 2025 $3.6M Details
Debt Financing 2025 $600k Details
Venture - Series Unknown 2023 $7M Details
Debt Financing 2022 $5M Details
Venture - Series Unknown 2021 $4.2M Details
Venture - Series Unknown 2019 $5.7M Details
Venture - Series Unknown 2018 $4M Details